SuperSonic Imagine Reports Validation of Clinical Benefits of ShearWave™ Elastography

March 5th, 2011 (Aix-en-Provence, France). SuperSonic Imagine presented yesterday the validation of a world wide multicentre study, based on European recruitment, confirming the benefit of ShearWave Elastography when added to ultrasound for improved lesion classification.

Launched by SuperSonic Imagine in June 2008, the global, multi-centre study was conducted across 16 American and European sites involving 1,800 patients with breast lesions. The first major result of this study demonstrated that ShearWave Elastography is reproducible both quantitatively and qualitatively.

This reproducible technology provides strong assurance of precise tissue evaluation during diagnosis and is expected to be also useful in follow-up.The second important outcome is a model based on 939 lesions, which showed that ShearWave Elastography increases the performance of ultrasound breast cancer diagnosis.The addition of ShearWave Elastography features, such as maximum elasticity (stiffness) or heterogeneity (uniformity) of a lesion, to B-mode ultrasound, would permit an improvement in the BI-RADS® classification accuracy, standardization tool for breast lesion classificationfrom the American College of Radiology) improving breast diagnosis.

source: Supersonic Imagine